We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > ADC Bio

News List

NEW STATE OF THE ART CLEANROOM COMPLETED BY WHP FOR ADC BIO biospectrumasia
July 17, 2019
The GMP facility has been specifically designed to deliver the next generation of anticancer blockbuster ADC drugs for patients globally
ADC Bio secures additional equity round investment cphi-online
November 27, 2018
ADC Biotechnology (ADC Bio) has secured additional funding of £2.5 million from existing investors and company management. The finance will be deployed to ensure the achievement of specific
ADC Bio secures £1.14m investment from Downing LLP to finance innovative bioconjugation and US expansion biospace
April 26, 2018
ADC Biotechnology (ADC Bio), announces that it has secured £1.14 million in funding from investment managers, Downing LLP. The funds will bolster the company’s business drive for faster penetration of the main US market.
ADC Bio signs agreement with sector specialists WHP biospectrumasia
December 07, 2017
Construction on state of the art bioconjugation facility for clinical and commercial ADC drug manufacturing to begin immediately
ADC Bio to Bioconjugation facility receives $11 million investment pharmaasia
September 28, 2017
Customer demand for ‘Lock-Release’ aggregation control technology a key driver behind the ADC Bio expansion into clinical and commercial drug manufacturing.